George Lau to Male
This is a "connection" page, showing publications George Lau has written about Male.
Connection Strength
0.050
-
Effect of COVID-19 on patients with compensated chronic liver diseases. Hepatol Int. 2020 Sep; 14(5):701-710.
Score: 0.012
-
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol. 2020 08; 73(2):451-453.
Score: 0.012
-
Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis. Hepatology. 2017 07; 66(1):13-26.
Score: 0.010
-
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score. Clin Infect Dis. 2020 09 12; 71(6):1393-1399.
Score: 0.003
-
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020 Sep; 14(5):690-700.
Score: 0.003
-
Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study. J Gastroenterol Hepatol. 2017 Dec; 32(12):1989-1997.
Score: 0.003
-
Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases. Sci Rep. 2017 11 28; 7(1):16482.
Score: 0.003
-
Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure. Liver Int. 2017 10; 37(10):1497-1507.
Score: 0.002
-
ANGPTL8 (Betatrophin) is Expressed in Visceral Adipose Tissue and Relates to Human Hepatic Steatosis in Two Independent Clinical Collectives. Horm Metab Res. 2017 May; 49(5):343-349.
Score: 0.002